{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative adjective directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_19084", "batch_size": 200, "batch_pos": 151, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 2, "answer": "no", "rationale": "The segment reports factual history without using high-potency verbs, metaphors, superlatives, intensifiers, or critical alert phrases.", "method": "llm_batch", "batch_id": "batch_2_20184", "batch_size": 200, "batch_pos": 135, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 3, "answer": "no", "rationale": "No moderate verb paired with explicit scale or impact information.", "method": "llm_batch", "batch_id": "batch_3_16692", "batch_size": 200, "batch_pos": 106, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_16596", "batch_size": 200, "batch_pos": 105, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 5, "answer": "no", "rationale": "The segment discusses the history of research but contains no explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_15656", "batch_size": 200, "batch_pos": 103, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 6, "answer": "no", "rationale": "The segment does not contain a minimiser combined with a scale contrast.", "method": "llm_batch", "batch_id": "batch_6_20272", "batch_size": 200, "batch_pos": 88, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_20104", "batch_size": 200, "batch_pos": 86, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 8, "answer": "no", "rationale": "The segment describes past research history, not a current capability or preparedness measure.", "method": "llm_batch", "batch_id": "batch_8_19312", "batch_size": 200, "batch_pos": 15, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 9, "answer": "no", "rationale": "Describes vaccine research history, not reporting prices or metrics.", "method": "llm_batch", "batch_id": "batch_9_7020", "batch_size": 200, "batch_pos": 89, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 10, "answer": "no", "rationale": "The segment describes vaccine research origin, not speculation about future relief.", "method": "llm_batch", "batch_id": "batch_10_5564", "batch_size": 200, "batch_pos": 200, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 11, "answer": "no", "rationale": "Attribution 'said Raffael Nachbagauer' but no direct quotation.", "method": "llm_batch", "batch_id": "batch_11_20212", "batch_size": 200, "batch_pos": 200, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 12, "answer": "yes", "rationale": "No explicit framing cues found; facts presented neutrally.", "method": "llm_batch", "batch_id": "batch_12_18348", "batch_size": 200, "batch_pos": 200, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
